Back to search

Article

Elucidating the Type 2 Diabetes Regulatory Network: Identification of EGFR as a Key Hub and Novel Drug Candidates

2024-07-11

Abstract excerpt

<h4>Introduction</h4> Type 2 diabetes (T2D) is a complex metabolic disorder with incompletely understood molecular mechanisms. This study aimed to elucidate the T2D regulatory network and identify potential drug targets and candidates. <h4>Methods</h4> We performed differential gene expression analysis on multiple T2D datasets, constructed protein-protein interaction networks, and conducted a meta-analysis to id...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6e271d41-5e54-543c-8fbf-98869da3e508
DOI
10.1101/2024.07.08.602441
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Elucidating the Type 2 Diabetes Regulatory Network: Identification of EGFR as a Key Hub and Novel Drug CandidatesDOI 10.1101/2024.07.08.602441
Epidermal growth factor receptor (EGFR) as a key regulator in type 2 diabetes: Drug discovery insightsSemantic proximity
Multi-omics regulatory networks reveal the key driver genes in the development of type 2 diabetesSemantic proximity
Uncovering the gene regulatory network of type 2 diabetes through multi-omic data integrationSemantic proximity
Integrative Gene Target Mapping, RNA Sequencing, In Silico Molecular Docking, ADMET Profiling and Molecular Dynamics Simulation Study of Marine Derived Molecules for Type 1 Diabetes MellitusSemantic proximity
Bioinformatics and network biology approach to identifying type 2 diabetes genes and pathways that influence the progression of breast cancerSemantic proximity
Single-Cell RNA Sequencing Analysis of Key Candidate Genes; Molecular Modeling and Docking-Based Therapeutic Molecules Exploration of Nature Derived Phytoconstituents for Type 2 Diabetes Mellitus.Semantic proximity
Transcriptome-Wide Identification of Hub Genes and Therapeutic Targets in Type 2 Diabetes Mellitus Through Integrated Bioinformatics and Molecular Docking-Based Drug RepurposingSemantic proximity
Exploring the therapeutic potential of Rutin and Morin in Type 2 Diabetes: A transcriptomics and molecular dynamics simulation for proteinsSemantic proximity
Bioinformatics Analysis of next generation sequencing data for Risk Prediction in Patients with Type 1 diabetes mellitusSemantic proximity
Identification and analysis of key genes and signaling pathways associated with Type 1 diabetes mellitus by bioinformatics analysis of next generation sequencing dataSemantic proximity
Identification of key genes, biological functions, and pathways of empagliflozin by network pharmacology and its significance in the treatment of type 2 diabetes mellitusSemantic proximity
Highly perturbed genes and hub genes associated with type 2 diabetes in different tissues of adult humans: A bioinformatics analytic workflowSemantic proximity
Select a neighboring publication to make it the new centre.